These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7622436)
61. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides. Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433 [TBL] [Abstract][Full Text] [Related]
62. Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitors. Gelain A; Bettinelli I; Barlocco D; Kwon BM; Jeong TS; Cho KH; Toma L J Med Chem; 2005 Dec; 48(24):7708-13. PubMed ID: 16302810 [TBL] [Abstract][Full Text] [Related]
63. Guineensine, an Acyl-CoA: cholesterol acyltransferase inhibitor, from the fruits of Piper longum. Lee SW; Rho MC; Nam JY; Lim EH; Kwon OE; Kim YH; Lee HS; Kim YK Planta Med; 2004 Jul; 70(7):678-9. PubMed ID: 15254860 [TBL] [Abstract][Full Text] [Related]
64. Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas. Xu MZ; Lee WS; Kim MJ; Park DS; Yu H; Tian GR; Jeong TS; Park HY Bioorg Med Chem Lett; 2004 Aug; 14(16):4277-80. PubMed ID: 15261286 [TBL] [Abstract][Full Text] [Related]
65. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors. Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793 [TBL] [Abstract][Full Text] [Related]
66. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety. Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9439694 [TBL] [Abstract][Full Text] [Related]
67. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity. Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599 [TBL] [Abstract][Full Text] [Related]
68. Polyacetylenic compounds, ACAT inhibitors from the roots of Panax ginseng. Rho MC; Lee HS; Lee SW; Chang JS; Kwon OE; Chung MY; Kim YK J Agric Food Chem; 2005 Feb; 53(4):919-22. PubMed ID: 15712998 [TBL] [Abstract][Full Text] [Related]
70. On the mechanism of the modulation in vitro of acyl-CoA:cholesterol acyltransferase by progesterone. Synouri-Vrettakou S; Mitropoulos KA Biochem J; 1983 Oct; 215(1):191-9. PubMed ID: 6626174 [TBL] [Abstract][Full Text] [Related]
72. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Synthesis and hypocholesterolemic activity of dibenz[b,e]oxepin-11-carboxanilides. Kumazawa T; Yanase M; Harakawa H; Obase H; Shirakura S; Ohishi E; Oda S; Kubo K; Yamada K J Med Chem; 1994 Mar; 37(6):804-10. PubMed ID: 8145231 [TBL] [Abstract][Full Text] [Related]
73. Inhibition of acyl coenzyme A: cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate). Heffron F; Middleton B; White DA Biochem Pharmacol; 1990 Feb; 39(3):575-80. PubMed ID: 2306268 [TBL] [Abstract][Full Text] [Related]
74. Dual modulation of hepatic and intestinal acyl-CoA: cholesterol acyltransferase activity by (de-)phosphorylation and substrate supply in vitro. Suckling KE; Stange EF; Dietschy JM FEBS Lett; 1983 Jan; 151(1):111-6. PubMed ID: 6825835 [TBL] [Abstract][Full Text] [Related]
75. Acyl-CoA : cholesterol acyltransferase inhibitors from Magnolia obovata. Kwon BM; Kim MK; Lee SH; Kim JA; Lee IR; Kim YK; Bok SH Planta Med; 1997 Dec; 63(6):550-1. PubMed ID: 9434609 [TBL] [Abstract][Full Text] [Related]
76. Active conformation of seven-membered-ring benzolactams as new ACAT inhibitors: latent chirality at N5 in the 1,5-benzodiazepin-2-one nucleus. Tabata H; Wada N; Takada Y; Nakagomi J; Miike T; Shirahase H; Oshitari T; Takahashi H; Natsugari H Chemistry; 2012 Feb; 18(6):1572-6. PubMed ID: 22213135 [No Abstract] [Full Text] [Related]
77. Effect of exogenous cholesterol and dithiothreitol on the activity of human liver microsomal acyl-coenzyme A:cholesterol acyltransferase (ACAT). Smith JL; Madden LJ; de Jersey J Clin Chim Acta; 1996 Dec; 256(1):13-25. PubMed ID: 8960784 [TBL] [Abstract][Full Text] [Related]
78. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. Vaziri ND; Liang K Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162 [TBL] [Abstract][Full Text] [Related]
79. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia. Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu H; Rudel LL; Omura S; Ishibashi S; Tomoda H Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1108-15. PubMed ID: 21393580 [TBL] [Abstract][Full Text] [Related]
80. Glisoprenins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gliocladium sp. FO-1513. II. Structure elucidation of glisoprenins A and B. Nishida H; Huang XH; Tomoda H; Omura S J Antibiot (Tokyo); 1992 Oct; 45(10):1669-76. PubMed ID: 1473995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]